University of Toronto
3359 Mississauga Road N.
Mississauga
Ontario
L5L 1C6
Canada
Tel: 905-828-5399
Fax: 905-569-4301
Website: http://www.utm.utoronto.ca/
224 articles about University of Toronto
-
New AI Tool Makes Speedy Gene-Editing Possible
1/26/2023
The researchers at NYU Grossman School of Medicine and the University of Toronto who designed the tool say it promises to accelerate the development of gene therapies on a large scale.
-
The partnership framework agreement allows Moderna and U of T to collaborate across a broad variety of areas, ranging from molecular genetics to biomedical engineering, biochemistry and more.
-
Recent technological advancements have pushed pharma employees to embrace new technologies and innovations in different areas.
-
At this time, 73% of Americans are immune to Omicron, and it could rise to 80% by mid-March. For that and more COVID-19 news, continue reading.
-
AbbVie and the University of Toronto Establish Endowed Chair in Ethnodermatology
2/15/2022
AbbVie has made a CDN $3-million donation to establish a pioneering AbbVie Chair in Ethnodermatology at the University of Toronto's Temerty Faculty of Medicine.
-
Creative Destruction Lab Joins University of Washington’s Foster School of Business, Establishing CDL-Seattle
5/20/2021
Focus on Computational Health Merges Strengths in Artificial Intelligence and Machine Learning with Biological and Biomedical Expertise to Launch Companies That Revolutionize Diagnostic and Therapeutic Outcomes
-
Sansero Life Sciences Announces Joint Study With the University of Toronto to Advance Clinical Research of Psychedelic Medications
10/1/2020
Sansero Life Sciences , a leader in the development of psilocybin-based medicines, announced today that it has partnered with the University of Toronto to complete a preclinical study on the effects of low-dose psilocybin. The study will bring new scientific understanding to psilocybin metabolism in the mammalian body and
-
Researchers at the University of Toronto have identified a protein called Importin-11 that transports beta-catenin into the nucleus of colon cancer cells, where it drives cell proliferation.
-
Absolute Antibody Partners with the Recombinant Antibody Network to Facilitate Access to Engineered Recombinant Antibodies
12/3/2019
200+ recombinant antibodies to be engineered into new formats to advance research
-
FACIT and University of Toronto launch precision medicine company: Cellular Analytics
10/30/2019
Next generation liquid biopsy platform to revolutionize companion diagnostics
-
A team of researchers from the University of Toronto has combined CRISPR-based gene-editing technology with small biomagnetic devices to sort large populations of mixed cell types.
-
University of Toronto and Amgen Foundation Welcome Canadian Students to Prestigious Amgen Scholars Program
6/6/2019
For the first time, Amgen Foundation grant offers Canadian undergraduate students the opportunity to gain hands-on research experience with world-leading U of T researchers
-
Mothers Know Best: How Egg Cells Choose Their Best Powerhouses to Pass On
5/15/2019
Developing egg cells conduct tests to select the healthiest of their energy-making machines to be passed to the next generation.
-
St. Baldrick's Foundation Awards One-of-a-Kind Grant to Aid in Childhood Cancer Research Discovery
5/3/2019
St. Baldrick's Robert J. Arceci Innovation Award provides scientists opportunity to pursue unrestricted research
-
University of Toronto Partners with IMS for Emergency Radiology Simulation
5/1/2019
IMS Web Viewer™ Selected for ER Simulator Exam Study
-
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
-
Research Roundup: Gene Therapy for Deafness, Autism Genes, Breakthroughs in Parkinson’s and ALS, ...
3/1/2019
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them. -
Boehringer Ingelheim and Eli Lilly released data from their Empagliflozin as Adjunctive to inSulin thErapy (EASE) Phase III trial in type 1 diabetes.
-
CCAB And Triumvira Immunologics Announce Triumvira’s License Agreement with University of Toronto for the Discovery of Antibody Drug Development Candidates
9/10/2018
The agreement provides Triumvira with an exclusive license for antibodies discovered at the U of T on specified therapeutic targets.
-
Medicine by Design and Creative Destruction Lab partner to accelerate the commercialization of world-class research in regenerative medicine
7/25/2018
A new partnership between Medicine by Design and the Creative Destruction Lab (CDL) will strengthen Toronto's biomedical ecosystem by bringing together the University of Toronto's (U of T) world-class research in regenerative medicine and the CDL's proven seed-stage program for science-based companies.